Urogesic Blue Drug Interactions
Currently displaying 7 drugs known to have a minor interaction with Urogesic Blue (hyoscyamine / methenamine / methylene blue / sodium biphosphate).
- 248 major drug interactions
- 376 moderate drug interactions
- 7 minor drug interactions
Minor interactions with Urogesic Blue (hyoscyamine / methenamine / methylene blue / sodium biphosphate)
Note: Showing generic names only.
Urogesic Blue alcohol/food interactions
There are 3 alcohol/food interactions with Urogesic Blue (hyoscyamine / methenamine / methylene blue / sodium biphosphate).
Urogesic Blue disease interactions
There are 29 disease interactions with Urogesic Blue (hyoscyamine / methenamine / methylene blue / sodium biphosphate) which include:
- autonomic neuropathy
- GI obstruction
- glaucoma
- obstructive uropathy
- reactive airway diseases
- myasthenia gravis
- infectious diarrhea
- inflammatory bowel disease
- intestinal obstruction disorders
- crystalluria
- gout
- liver disease
- methemoglobinemia in G-6-PD
- hypocalcemia
- phosphate imbalance
- electrolyte imbalance
- cardiac disease
- tachycardia
- coronary artery disease
- gastric ulcer
- gastroesophageal reflux
- ulcerative colitis
- liver disease
- renal failure
- renal dysfunction
- hypertension
- hyperthyroidism
- diarrhea
- fever
More about Urogesic Blue (hyoscyamine / methenamine / methylene blue / sodium biphosphate)
- Urogesic Blue consumer information
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (7)
- Drug images
- Side effects
- Dosage information
- Drug class: urinary antispasmodics
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.